Netherlands Insider Trading Transactions
Latest insider transactions reported to the AFM
Showing 4801 – 4850 of 7,506 transactions
| Issuer | Insider | Position | Transaction | Price | Volume | Transaction Date | Trading Venue | Details |
|---|---|---|---|---|---|---|---|---|
| Aegon Ltd. | Jäkel A. | Aegon Ltd. Board of Directors | Verwerving | EUR 0.00 | EUR 0.00 | 07 Jul 2025 | OTC | |
| Aegon Ltd. | McGarry J. | Aegon Ltd. Board of Directors | Verwerving | EUR 0.00 | EUR 0.00 | 07 Jul 2025 | EURONEXT - EURONEXT AMSTERDAM | |
| Aegon Ltd. | Johnson S. | Aegon Ltd. Executive Committee | Verwerving | EUR 0.00 | EUR 0.00 | 07 Jul 2025 | EURONEXT - EURONEXT AMSTERDAM | |
| Aegon Ltd. | Friese L. | Aegon Ltd. Board of Directors | Verwerving | EUR 0.00 | EUR 0.00 | 07 Jul 2025 | EURONEXT - EURONEXT AMSTERDAM | |
| Aegon Ltd. | Caldera E. | Aegon Ltd. Executive Committee | Verwerving | EUR 0.00 | EUR 0.00 | 07 Jul 2025 | OTC | |
| Aegon Ltd. | Waters D. | Aegon Ltd. Board of Directors | Verwerving | EUR 0.00 | EUR 0.00 | 07 Jul 2025 | OTC | |
| Aegon Ltd. | Keim M.B.A. | Aegon Ltd. Executive committee | Verwerving | EUR 0.00 | EUR 0.00 | 07 Jul 2025 | OTC | |
| Aegon Ltd. | Bareggi M.A.E. | Aegon Ltd. Executive Committee | Verwerving | EUR 0.00 | EUR 0.00 | 07 Jul 2025 | OTC | |
| Aegon Ltd. | Wellauer T. | Aegon Ltd. Board of DIrectors | Verwerving | EUR 0.00 | EUR 0.00 | 07 Jul 2025 | OTC | |
| Aegon Ltd. | Connelly W. | Aegon Ltd. Board of Directors | Verwerving | EUR 0.00 | EUR 0.00 | 07 Jul 2025 | OTC | |
| argenx SE | Massey K. | Chief Operating Officer | Verwerving | EUR 0.00 | EUR 0.00 | 03 Jul 2025 | OTC | |
| argenx SE | Wilk A. | Global Head of Quality | Verwerving | EUR 0.00 | EUR 0.00 | 03 Jul 2025 | OTC | |
| argenx SE | Lemmen A. | Vice President of Corporate Development & Strategy | Verwerving | EUR 0.00 | EUR 0.00 | 03 Jul 2025 | OTC | |
| argenx SE | Ulrichts P. | Schief Scientific Officer | Verwerving | EUR 0.00 | EUR 0.00 | 03 Jul 2025 | OTC | |
| argenx SE | Truyen L. | Chief Medical Officer | Verwerving | EUR 0.00 | EUR 0.00 | 03 Jul 2025 | OTC | |
| argenx SE | Gubitz K. | Chief Financial Officer | Verwerving | EUR 0.00 | EUR 0.00 | 03 Jul 2025 | OTC | |
| argenx SE | Moorthy H. | General Counsel | Verwerving | EUR 0.00 | EUR 0.00 | 03 Jul 2025 | OTC | |
| argenx SE | Massey K. | Chief Operating Officer | Vervreemding | EUR 0.00 | EUR 0.00 | 03 Jul 2025 | OTC | |
| argenx SE | Wilk A. | Global Head of Quality | Vervreemding | EUR 0.00 | EUR 0.00 | 03 Jul 2025 | OTC | |
| argenx SE | Lemmen A. | Vice President of Corporate Development & Strategy | Vervreemding | EUR 0.00 | EUR 0.00 | 03 Jul 2025 | OTC | |
| argenx SE | Ulrichts P. | Schief Scientific Officer | Vervreemding | EUR 0.00 | EUR 0.00 | 03 Jul 2025 | OTC | |
| argenx SE | Truyen L. | Chief Medical Officer | Vervreemding | EUR 0.00 | EUR 0.00 | 03 Jul 2025 | OTC | |
| argenx SE | Gubitz K. | Chief Financial Officer | Vervreemding | EUR 0.00 | EUR 0.00 | 03 Jul 2025 | OTC | |
| argenx SE | Moorthy H. | General Counsel | Vervreemding | EUR 0.00 | EUR 0.00 | 03 Jul 2025 | OTC | |
| argenx SE | Massey K. | Chief Operating Officer | Verwerving | EUR 0.00 | EUR 0.00 | 03 Jul 2025 | OTC | |
| argenx SE | Wilk A. | Global Head of Quality | Verwerving | EUR 0.00 | EUR 0.00 | 03 Jul 2025 | OTC | |
| argenx SE | Lemmen A. | Vice President of Corporate Development & Strategy | Verwerving | EUR 0.00 | EUR 0.00 | 03 Jul 2025 | OTC | |
| argenx SE | Ulrichts P. | Schief Scientific Officer | Verwerving | EUR 0.00 | EUR 0.00 | 03 Jul 2025 | OTC | |
| argenx SE | Truyen L. | Chief Medical Officer | Verwerving | EUR 0.00 | EUR 0.00 | 03 Jul 2025 | OTC | |
| argenx SE | Gubitz K. | Chief Financial Officer | Verwerving | EUR 0.00 | EUR 0.00 | 03 Jul 2025 | OTC | |
| argenx SE | Moorthy H. | General Counsel | Verwerving | EUR 0.00 | EUR 0.00 | 03 Jul 2025 | OTC | |
| Ariston Holding N.V. | Giuliani E. | Executive Chairman | Vervreemding | EUR 0.00 | EUR 0.00 | 01 Jul 2025 | OTC | |
| Ariston Holding N.V. | Merloni F. | Executive Chairman | Verwerving | EUR 0.00 | EUR 0.00 | 01 Jul 2025 | OTC | |
| Ariston Holding N.V. | Merloni C. | Executive Chairman | Verwerving | EUR 0.00 | EUR 0.00 | 01 Jul 2025 | OTC | |
| Ariston Holding N.V. | Merloni E. | Executive Chairman | Verwerving | EUR 0.00 | EUR 0.00 | 01 Jul 2025 | OTC | |
| argenx SE | Gubitz K. | Chief Financial Officer | Verwerving | EUR 0.00 | EUR 0.00 | 01 Jul 2025 | OTC | |
| argenx SE | Gubitz K. | Chief Financial Officer | Vervreemding | EUR 0.00 | EUR 0.00 | 01 Jul 2025 | OTC | |
| Ariston Holding N.V. | Giuliani E. | Executive Chairman | Vervreemding | EUR 0.00 | EUR 0.00 | 01 Jul 2025 | OTC | |
| Ariston Holding N.V. | Merloni F. | Executive Chairman | Verwerving | EUR 0.00 | EUR 0.00 | 01 Jul 2025 | OTC | |
| Ariston Holding N.V. | Merloni C. | Executive Chairman | Verwerving | EUR 0.00 | EUR 0.00 | 01 Jul 2025 | OTC | |
| Ariston Holding N.V. | Merloni E. | Executive Chairman | Verwerving | EUR 0.00 | EUR 0.00 | 01 Jul 2025 | OTC | |
| argenx SE | Gubitz K. | Chief Financial Officer | Verwerving | EUR 0.00 | EUR 0.00 | 01 Jul 2025 | OTC | |
| Universal Music Group N.V. | Ellis M.D. | Chief Financial Officer | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| Universal Music Group N.V. | Ellis M.D. | Chief Financial Officer | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| argenx SE | Moorthy H. | General Counsel | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| NN Group N.V. | Nihot D. | Management Board Member NN Group N.V. | Vervreemding | EUR 56.28 | EUR 292,993.68 | 30 Jun 2025 | OTC | |
| Banijay Group N.V. | Vivendi SE | Non-Executive Director of Banijay Group N.V. | Vervreemding | EUR 8.55 | EUR 172,342.35 | 30 Jun 2025 | EURONEXT - EURONEXT AMSTERDAM | |
| argenx SE | Massey K. | Chief Operating Officer | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| Universal Music Group N.V. | Ellis M. | Chief Financial Officer | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| argenx SE | Lemmen A. | Vice President of Corporate Development & Strategy | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC |